293 related articles for article (PubMed ID: 12014425)
1. The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice.
Pfister K; Wittig BM; Jüngling B; Ecker KW; Barth S; Huhn M; Sasse S; Engert A; Mueller-Molaian I; Diehl V; Zeitz M; Stallmach A
Int J Colorectal Dis; 2002 Mar; 17(2):77-84. PubMed ID: 12014425
[TBL] [Abstract][Full Text] [Related]
2. Recombinant anti-CD25 immunotoxin RFT5(SCFV)-ETA' demonstrates successful elimination of disseminated human Hodgkin lymphoma in SCID mice.
Barth S; Huhn M; Matthey B; Schnell R; Tawadros S; Schinköthe T; Lorenzen J; Diehl V; Engert A
Int J Cancer; 2000 Jun; 86(5):718-24. PubMed ID: 10797296
[TBL] [Abstract][Full Text] [Related]
3. Construction and in vitro evaluation of RFT5(scFv)-ETA', a new recombinant single-chain immunotoxin with specific cytotoxicity toward CD25+ Hodgkin-derived cell lines.
Barth S; Huhn M; Wels W; Diehl V; Engert A
Int J Mol Med; 1998 Jan; 1(1):249-56. PubMed ID: 9852227
[TBL] [Abstract][Full Text] [Related]
4. Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization?
Shen C; de Hertogh G; Bullens DM; Van Assche G; Geboes K; Rutgeerts P; Ceuppens JL
Inflamm Bowel Dis; 2007 Mar; 13(3):308-16. PubMed ID: 17206708
[TBL] [Abstract][Full Text] [Related]
5. Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.
Popp V; Gerlach K; Mott S; Turowska A; Garn H; Atreya R; Lehr HA; Ho IC; Renz H; Weigmann B; Neurath MF
Gastroenterology; 2017 Jan; 152(1):176-192.e5. PubMed ID: 27639807
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6.
Mudter J; Amoussina L; Schenk M; Yu J; Brüstle A; Weigmann B; Atreya R; Wirtz S; Becker C; Hoffman A; Atreya I; Biesterfeld S; Galle PR; Lehr HA; Rose-John S; Mueller C; Lohoff M; Neurath MF
J Clin Invest; 2008 Jul; 118(7):2415-26. PubMed ID: 18535667
[TBL] [Abstract][Full Text] [Related]
7. Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
Sato T; Kanai T; Watanabe M; Sakuraba A; Okamoto S; Nakai T; Okazawa A; Inoue N; Totsuka T; Yamazaki M; Kroczek RA; Fukushima T; Ishii H; Hibi T
Gastroenterology; 2004 Mar; 126(3):829-39. PubMed ID: 14988837
[TBL] [Abstract][Full Text] [Related]
8. Effect of Trichinella spiralis intervention on TNBS-induced experimental colitis in mice.
Xu J; Yu P; Wu L; Liu M; Lu Y
Immunobiology; 2019 Jan; 224(1):147-153. PubMed ID: 30413272
[TBL] [Abstract][Full Text] [Related]
9. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
10. Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice.
Engert A; Martin G; Amlot P; Wijdenes J; Diehl V; Thorpe P
Int J Cancer; 1991 Sep; 49(3):450-6. PubMed ID: 1917143
[TBL] [Abstract][Full Text] [Related]
11. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
12. Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis.
Yang X; Meng S; Jiang H; Chen T; Wu W
Scand J Gastroenterol; 2010 Oct; 45(10):1168-77. PubMed ID: 20469967
[TBL] [Abstract][Full Text] [Related]
13. Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models.
Maerten P; Shen C; Colpaert S; Liu Z; Bullens DA; van Assche G; Penninckx F; Geboes K; Vanham G; Rutgeerts P; Ceuppens JL
Clin Exp Immunol; 2004 Feb; 135(2):310-7. PubMed ID: 14738461
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
[TBL] [Abstract][Full Text] [Related]
15. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
[TBL] [Abstract][Full Text] [Related]
16. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath MF; Fuss I; Kelsall BL; Stüber E; Strober W
J Exp Med; 1995 Nov; 182(5):1281-90. PubMed ID: 7595199
[TBL] [Abstract][Full Text] [Related]
18. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.
Neurath MF; Fuss I; Kelsall BL; Presky DH; Waegell W; Strober W
J Exp Med; 1996 Jun; 183(6):2605-16. PubMed ID: 8676081
[TBL] [Abstract][Full Text] [Related]
19. Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease.
Van den Brande JM; Koehler TC; Zelinkova Z; Bennink RJ; te Velde AA; ten Cate FJ; van Deventer SJ; Peppelenbosch MP; Hommes DW
Gut; 2007 Apr; 56(4):509-17. PubMed ID: 17082252
[TBL] [Abstract][Full Text] [Related]
20. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.
Daniel C; Sartory N; Zahn N; Geisslinger G; Radeke HH; Stein JM
J Immunol; 2007 Feb; 178(4):2458-68. PubMed ID: 17277153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
